טוען...
Pharmacogenomic potential in advanced cancer patients
PURPOSE: The prevalence of pharmacogenetically actionable medications in advanced cancer patients whose therapy may be optimized with genotype data was determined. METHODS: Patients enrolled in our institutional molecular tumor board observational cohort were included in this study. Collected data i...
שמור ב:
| הוצא לאור ב: | Am J Health Syst Pharm |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7936720/ https://ncbi.nlm.nih.gov/pubmed/31361818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajhp/zxy079 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|